AAP
ORGO icon

Arax Advisory Partners’s Organogenesis Holdings ORGO Stock Holding History

Arax Advisory Partners’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Buy
4,277
+3,863
+933% +$9.44K ﹤0.01% 4314
2026
Q1 		$982 Sell
414
-22
-5% -$76 ﹤0.01% 3301
2025
Q4 		$2.26K Sell
436
-58
-12% -$281 ﹤0.01% 3214
2025
Q3 		$2.08K Buy
+494
New +$2.3K ﹤0.01% 3107
2025
Q1 		– Sell
-2,311
Closed -$7.4K – 2941
2024
Q4 		$7.4K Hold
2,311
– – ﹤0.01% 1596
2024
Q3 		$6.61K Hold
2,311
– – ﹤0.01% 1587
2024
Q2 		$6.47K Buy
+2,311
New +$6.2K ﹤0.01% 1475

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Arax Advisory Partners's ORGO Position: Q2 2026 in Review

Arax Advisory Partners increased its Organogenesis Holdings (ORGO) stake by 933% in Q2 2026, buying an estimated $9.44K and bringing the position to 4,277 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4314.

Arax Advisory Partners first reported a position in ORGO in Q2 2024 and has held it in 7 quarters since. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Arax Advisory Partners held 4,277 shares of Organogenesis Holdings worth $10.4K as of Q2 2026.
  • Arax Advisory Partners bought 3,863 Organogenesis Holdings shares in Q2 2026, an estimated $9.44K.
  • Organogenesis Holdings made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4314 holding.
  • Arax Advisory Partners first reported a position in Organogenesis Holdings in Q2 2024 and has held it in 7 quarters since.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.